Tagged with Generic

Austria Ard van der Meij, country president of Novartis Group Austria, the nation’s leading pharmaceutical company, discusses the advantages in Austria for innovative companies and the steps required to bolster the generics and biosimilars market share within the Austrian market to create a sustainable healthcare ecosystem for the long-term. Furthermore, he…

Austria Siegfried Leitner, general manager of Accord Austria and Germany, and CEO and co-founder of A-med, provides an insight into the early years of his Accord affiliate and how it was able to establish itself in Austria and elaborates on the current portfolio of Accord in Austria. He also provides an…

Ukraine Dr. Paul Melekhov, vice president Eastern Europe at Pharmascience, Canada’s third largest generic company, provides insights into the unique history of Pharmascience in Ukraine and the pioneering market approach that he has been implementing in the country over the past 25 years. Leveraging its long-standing experience of the Ukrainian market,…

Austria Dr. Erwin Klein, CEO and co-founder of easypharm, a generics and OTC company founded by Austrians for Austria, provides an overview of his exciting entrepreneurial experience and the challenges associated with establishing a new pharmaceutical company in Austria as well as his expert view on the current healthcare system. He…

Colombia Emilio Sardi, vice-president of Tecnoquimicas, the local champion in production and distribution of generic pharmaceutical drugs, shares his insights on his current priorities to enter the biotechnology field, grow their international operations focusing on Central American countries and further strengthen the company’s exceptional capacity to launch new products.   The…

Austria Dr. Wolfgang Andiel, president of the Austrian Association of Generic Medicines (OeGV, Österreichischer Generikaverband), which acts as a unified voice to represent generics companies in Austria, provides an in-depth analysis of the vicious cycle associated with establishing generics market share in Austria as well as the inconsistences of government regulations…

Colombia Sunil Dhyani, general manager of IPCA in Colombia, a successful Indian firm continuously launching new molecules, shares his take on the company’s strategy decisions in Colombia, as well as wider opportunities in Latin America. How does Colombia differentiate itself from other markets in the region? “Colombia offers a great political…

Ukraine Rajeev Gupta, co-founder and MD of Kusum Group, the largest Indian company in Ukraine, providing domestically produced generic treatments to the Ukrainian market, describes the challenges of the procurement process and the difficulties of creating brand recognition and respect as an Indian company. Please begin by introducing Kusum Group and…

Colombia Latin American Regional Head of MSN Labs, one of the most promising generics companies globally, Raman Wattamwar, speaks about the strength of the newly-formed affiliate in Colombia. He highlights Colombia’s optimal potential as a regional hub, the positive business environment for foreign generics players, as well as his overarching strategic…

Ukraine Dmytro Spitsyn, General Manager of Teva Ukraine, which proudly stands as the largest international company operating in the country, documents the challenges he faced and the strategies he implemented to overcome the 2013 crisis in Ukraine, while Teva has been positioning itself as a company committed to increasing life expectancy…

Colombia Aurobindo’s regional head, Kamlesh Thakkar, discusses how the company is truly benefiting the healthcare landscape in Colombia, while describing his experience in changing the mindset concerning the use of generics in the top hospitals of the country and shares the origins of Aurobindo’s healthier life campaign. To begin, Mr. Thakkar,…

Taiwan Samuel Wang, Honorary President of the Taiwan Generics Pharmaceutical Association (TGPA) and President of the local distributor Weal-Chance Trading, provides insights into the recent international achievements of TGPA and the main strengths of Taiwan’s generics industry on the global stage, while he explains how bolstering the country’s historical strengths in…